Filter content

Building on the success of its specialized residential treatment programs for “warriors”—active duty military, veterans, first responders, and EMTs/paramedics—Warriors Heart has launched Warriors Anonymous, a new AA specialty meeting for the same population. WA was developed by Warriors Heart…

In this video, psychiatrist Birgit Amann, MD, provides tips and strategies for clinicians treating attention-deficit/hyperactivity disorder (ADHD) through telepsychiatry during the COVID-19 pandemic.

BLOG: We know that isolation is one of the drivers of suicide in doctors. But listening to how doctors are affected in their heroic work on the front lines of the COVID-19 epidemic gives me hope that barriers to openly sharing one’s personal distress are lowering.

A synthetic molecule developed by researchers at Duke University has shown the ability to selectively dampen physiological rewards of cocaine in mice, according to research published in the journal Cell on Thursday.

With the COVID-19 crisis dominating our collective consciousness, many of us are imagining how this challenging experience will affect the future of healthcare design. While many great ideas and likely scenarios have been suggested, none are really applicable to psychiatric hospitals and behavioral…

Citing the efficacy of telehealth to maintain mental and behavioral healthcare treatment services during the COVID-19 pandemic, a group of industry associations has sent a letter to Seema Verma, administrator of the Centers for Medicare and Medicaid Services, asking that emergency regulations…

The US Food and Drug Administration has accepted the filing of a New Drug Application for an investigational amphetamine for the treatment of attention-deficit/hyperactivity disorder specifically designed to resist manipulation.

A “small but important” number of people will develop COVID-19–related psychosis, according to a rapid review published online in Schizophrenia Research.

Internet-delivered cognitive behavioral therapy was noninferior to conventional face-to-face CBT among patients with health anxiety, or hypochondriasis, according to a study published online in JAMA Psychiatry.